![Julie Krop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Krop
Directeur Technique/Scientifique/R&D chez
DIAMEDICA THERAPEUTICS INC.
Fortune : - $ au 31/05/2026
Profil
Julie Krop currently serves as Independent Director at Aquestive Therapeutics, Inc. since 2021, Chief Medical Officer at PureTech Health LLC since 2021, and Chief Medical Officer at DiaMedica Therapeutics, Inc. starting in 2025.
Former roles include Chief Medical Officer & Executive Vice President at AMAG Pharmaceuticals, Inc. from 2015 to 2021, Chief Medical Officer at Freeline Therapeutics Holdings Ltd. from 2020 to 2021, Chief Medical Officer & Head-Development at PureTech Health Plc from 2021 to 2024, Vice President-Clinical Development at Vertex Pharmaceuticals, Inc. from 2001 to 2015, VP-Clinical Development & Regulatory Affairs at Stryker Corp.
from 2006 to 2012, Vice President-Clinical Research at Peptimmune, Inc. from 2003 to 2006, Director-Clinical Research at Millennium Pharmaceuticals, Inc. from 2001 to 2003, and Associate Director at Pfizer Inc. from 1999 to 2001.
Education includes undergraduate studies at Brown University and a doctorate from The Warren Alpert Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 23/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Julie Krop
| Sociétés | Poste | Début |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/02/2021 |
| DIAMEDICA THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 11/08/2025 |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | 01/10/2021 |
Anciens postes connus de Julie Krop
| Sociétés | Poste | Fin |
|---|---|---|
| PURETECH HEALTH PLC | Directeur Technique/Scientifique/R&D | 31/03/2024 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/08/2021 |
| AMAG PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/05/2015 |
| STRYKER CORPORATION | Corporate Officer/Principal | 01/01/2012 |
Formation de Julie Krop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Stryker Corp.
 Stryker Corp. Medical SpecialtiesHealth Technology Manufactures and markets reconstructive, medical and surgical, and neurotechnology and spine products | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Warren Alpert Medical School
 The Warren Alpert Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Choisissez Zonebourse 
